
Jacobson Pharma Board to Review Interim Results and Dividend

I'm PortAI, I can summarize articles.
Jacobson Pharma Corporation Ltd. will hold a board meeting on November 18, 2025, to review interim results for the six months ending September 30, 2025, and to consider an interim dividend payment along with other business matters.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

